XiFin, a healthcare information technology provider specializing in AI-enabled revenue cycle management (RCM), announced substantial operational growth in 2025, marked by a 21.1% increase in volume through its AI-powered XiFin® Empower RCM solution and the strategic appointment of Sanjay Kumar as Chief Technology Officer to advance its AI innovation.
In 2025, XiFin reported significant growth across key segments, including a 16.4% rise in its molecular diagnostics segment and a 13.3% increase in its hospital segment. The company’s XiFin® Empower RCM solution saw a 21.1% increase in processing volume, indicating expanding adoption of its AI-driven revenue cycle platform.
Lâle White, Executive Chair and Chief Executive Officer of XiFin, commented on the results, stating, “Our performance in 2025 reflects more than strong results—it signals a structural shift toward intelligent, AI-driven revenue cycle infrastructure.” She added that the appointment of Sanjay Kumar to the leadership team would strengthen the company’s ability to execute on this vision, advancing cloud-native innovation and positioning XiFin in the future of healthcare financial operations.
Sanjay Kumar joins XiFin as Chief Technology Officer, bringing over two decades of experience in scaling cloud-native and AI-driven platform modernization across healthcare and technology sectors. His expertise is expected to be instrumental in rolling out advanced AI capabilities, particularly in emerging areas such as Medical Devices and Durable Medical Equipment (DME). Kumar previously served as CTO for ResMed’s $800M Residential Care Software business, where he led a multi-year transformation that unified fragmented product portfolios onto a single cloud-native platform, integrated machine learning and generative AI into clinical and revenue cycle workflows, and fostered AI-assisted software development, contributing to sustained double-digit growth.
Kumar expressed his view on joining the company, stating, “XiFin’s momentum, combined with its commitment to AI‑powered innovation, makes this an extraordinary time to join the organization.” He noted the potential to extend the impact of XiFin’s technology foundation with next-generation AI, agentic capabilities, and automation.
The XiFin Empower ecosystem continued to gain market traction, with its flagship solution, Empower RCM, seeing increased adoption among healthcare organizations. Global laboratory leader Sonic Healthcare expanded its deployment across multiple divisions in 2025, and precision medicine innovator Caris Life Sciences endorsed the solution’s impact on revenue cycle productivity. In 2025, XiFin also secured new capital investment, led by Goldman Sachs External Investing Group.
XiFin expanded its industry engagement and advocacy efforts, joining the Pharmacy Interoperability and Clinical Services Alliance (PICSA). This move aims to share insights and expertise while advancing interoperability standards and supporting pharmacists as clinical care providers, helping shape frameworks that improve access to clinical services and strengthen data exchange.
The company also enhanced its Board of Directors with the addition of Jeff Margolis, a healthcare IT executive with over 35 years of leadership experience. Margolis founded TriZetto, a vertical SaaS platform, and currently serves as a Senior Advisor to Blackstone, supporting strategic investments across healthcare and information technology.
XiFin received several recognitions in 2025 and 2026, including being named #1 in Black Book Market Research’s 2025 RCM Outsourcing Survey for cross-ancillary and outpatient laboratory services for the seventh consecutive year, and for outpatient radiology and diagnostic imaging RCM for the second year. It was also recognized in RXinsider’s 2026 Pharmacy500 and achieved HITRUST i1 Certification. Insights Care listed XiFin among its “Top 5 Revenue Cycle Management Companies of 2025,” and Silicon Review highlighted it as one of the “Global Best Companies to Watch in 2025.” The company also introduced the 2025 Specialty Pharmacy Transformation Outlook and published the 2025 Payor Denial Impact Report.
Members of XiFin’s leadership team also received individual recognition. CEO Lâle White was named to the “SD 500 of the Most Influential People in San Diego” by the San Diego Business Journal, which also recognized CFO Erik Sallee, Chief Legal and Compliance Officer Marty Barrack, Chief People Officer Niki Wallace, and SVP of Engineering & Analytics Jeff Carmichael. Marty Barrack was additionally recognized by Insights Success, while Sandra Greefkes, Ashley Keller, and Katie Williams were named “2025 Top Women in Health, Wellness & Beauty” by Drug Store News.
